Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Robertsen

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Transplantation Direct|March 6, 2023
Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant RecipientsOle Martin Drevland, Ida Robertsen, Marte Theie Gustavsen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 26, 2018
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort studyErlend Johannessen Egeland, Anna Varberg Reisaeter, Ida Robertsen, et al.
Microbiome|July 24, 2025
Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipientsOle Martin Drevland, Eric J de Muinck, Pål Trosvik, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 15, 2021
Increased systemic exposure of once-daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementationIda Robertsen, Anders Åsberg, Trond G Jenssen, et al.
Transplantation|February 14, 2014
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipientsIda Robertsen, Anders Asberg, Tone Granseth, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Transplantation|September 29, 2017
The Authors' ReplyErlend Johannessen Egeland, Elisabet Størset, Ida Robertsen, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Kidney International Reports|February 12, 2020
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol ClearanceAnders Åsberg, Anna Bjerre, Runar Almaas, et al.
Transplantation Direct|November 18, 2024
Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post-TacrolimusOle Martin Drevland, Marte Grasdal, Rasmus K Carlsen, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Transplantation Direct|March 6, 2023
Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant RecipientsOle Martin Drevland, Ida Robertsen, Marte Theie Gustavsen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 26, 2018
High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort studyErlend Johannessen Egeland, Anna Varberg Reisaeter, Ida Robertsen, et al.
Microbiome|July 24, 2025
Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipientsOle Martin Drevland, Eric J de Muinck, Pål Trosvik, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 15, 2021
Increased systemic exposure of once-daily tacrolimus in renal transplant recipients on marine omega-3 fatty acid supplementationIda Robertsen, Anders Åsberg, Trond G Jenssen, et al.
Transplantation|February 14, 2014
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipientsIda Robertsen, Anders Asberg, Tone Granseth, et al.
Clinical and Translational Science|July 12, 2020
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsMarte Theie Gustavsen, Karsten Midtvedt, Ida Robertsen, et al.
Transplantation|September 29, 2017
The Authors' ReplyErlend Johannessen Egeland, Elisabet Størset, Ida Robertsen, et al.
Diabetes Care|March 14, 2019
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes MellitusThea Anine Strøm Halden, Kine Eide Kvitne, Karsten Midtvedt, et al.
Kidney International Reports|February 12, 2020
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol ClearanceAnders Åsberg, Anna Bjerre, Runar Almaas, et al.
Transplantation Direct|November 18, 2024
Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post-TacrolimusOle Martin Drevland, Marte Grasdal, Rasmus K Carlsen, et al.
Pageof 5